FDA Approves New Omega-3 Supplement

The FDA has approved a new omega-3 supplement (brand name, Epanova) to 
treat adults with severe hypertriglyceridemia, defined as triglyceride 
levels 500 mg/dL or higher.

In its announcement, the manufacturer said that Epanova is the first 
omega-3 formulation approved by the FDA in free fatty acid form. It 
will be available in 1-g capsules and has been approved for 2-g and 4-
g dosages, which can be taken with or without food.

There are currently two other prescription formulations of omega-3 
supplements on the market: Lovaza and Vascepa. All three are approved 
only for the treatment of severe hypertriglyceridemia, though studies 
of expanded indications are underway.

By Larry Husten

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s